Senior Director, Head of Payer Strategy & Engagement

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.

The Senior Director, Head of Payer Strategy & Engagement will lead the development and execution of U.S. payer strategy and account engagement in support of the anticipated launch of deramiocel, Capricor's lead cell therapy for Duchenne muscular dystrophy. The role is responsible for constructing the payer value platform, shaping coverage and contracting strategy across commercial, Medicare, and Medicaid segments, and leading the National Account Director team to deliver timely and appropriate payer access decisions. This leader partners closely with Pricing & Contracting Operations, Market Access Analytics, Trade & Patient Services, Medical Affairs, HEOR, Legal, and Finance, as well as external payer leadership, advocacy organizations, and market access vendors.